Many pharmaceutical companies call Southern California home. The unique challenges facing these companies, from generic drug issues and related litigation, to complex licensing transactions, are among the areas of preeminent expertise at Stradling Yocca Carlson & Rauth. Our lawyers serving the pharmaceutical industry have developed an acute understanding of the challenges facing emerging pharmaceutical companies both public and private, and have handled billions of dollars worth of transactions for pharmaceutical companies as well as several bet-the-company litigations.

The firm’s value proposition to growing public pharmaceutical companies is its ability to perform a wide range of sophisticated legal services at a level on par with any law firm in the world, and at a value that is mindful of the challenges faced by emerging pharmaceutical companies.

We apply our 30-plus years of corporate experience to legal needs of our medical device clients in areas such as company formation, venture capital and other private financing, debt and lease financing, public offerings, securities law, executive compensation and employee incentive plans, and mergers and acquisitions.